Boston, MA -- (SBWIRE) -- 10/15/2013 -- Chartpoppers.com spends all day scouring the markets for the next huge Penny Stock Winner.Chartpoppers.com issues news alert on the following stocks:- OncoSec Medical Inc(OTCMKTS:ONCS), Morgan Stanley(NYSE:MS), Arena Pharmaceuticals, Inc.(NASDAQ:ARNA), Navidea Biopharmaceuticals Inc(NYSEMKT:NAVB)
OncoSec Medical Inc(OTCMKTS:ONCS) opened its shares at the price of $0.26 for the day. Its closing price was $0.254 after losing -1.21% for the day. The company traded with the total volume of 1.569 million shares, while its average trading volume remained 2.93 million shares. The beta of ONCS stands at 0.95. OncoSec Medical Incorporated, a drug-medical device and therapeutic company, designs, develops, and commercializes medical approaches for the treatment of solid tumors in the United States.
Has ONCS Found The Bottom and Ready To Move Up? Find Out Here
Morgan Stanley(NYSE:MS) percentage change surged +0.82% to close at $28.18 with the total traded volume of 11.93 million shares, and average volume of 13.82 million. The 52 week range of the stock remained $15.95 - $29.50, while its day lowest price was $27.50 and it hit its day highest price at $28.23. Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals worldwide.
For How Long MS’s Gloss will Attract Investors ? Find out via this report
Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) started its trading session with the price of $4.29 and closed at $4.34 by scoring -0.69%. ARNA’s stocks traded with total volume of 3.21 million shares, while the average trading volume remained 5.48 million shares. The beta of ARNA stands at 0.05. Day range of the stock was $4.21 -$4.36. Arena Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases.
Why Should Investors Buy ARNA After the Recent Fall? Just Go Here and Find Out
Navidea Biopharmaceuticals Inc(NYSEMKT:NAVB) ended its day with the loss of -4.94% and closed at the price of $2.31 after opening at $2.42. Stock traded during its last trading session with the total volume of 1.29 million shares, as compared to its average volume of 659,363.00 shares. Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision diagnostics and radiopharmaceutical agents
Will NAVB Get Buyers Even After The Recent Rally? Find Out Here
Chartpoppers.com spends all day scouring the markets for the next huge Penny Stock Winner. Investors have come to trust us for our up to date commentary on all hot stocks so please visit chartpoppers right now and see what it’s all about for yourself! At 50,000 Visitors a Month and growing rapidly chartpoppers is the hottest thing in Penny Stocks!
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list.
Never invest into a stock discussed on this web site or the ChartPoppers.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
ChartPoppers.com is owned and operated by One22 Media,LLC. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. ChartPoppers’s sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as a recommendation by ChartPoppers or an offer or solicitation to buy or sell any security. Neither the owner of ChartPoppers nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters.
Read Full Disclaimer at: http://chartpoppers.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)